[Steroid 21-hydroxylase deficiencies and female infertility: pathophysiology and management]
- PMID: 24852906
- DOI: 10.1016/j.gyobfe.2014.04.005
[Steroid 21-hydroxylase deficiencies and female infertility: pathophysiology and management]
Abstract
Steroid 21-hydroxylase deficiency is the most common adrenal genetic disease and is also named congenital adrenal hyperplasia. Depending on the severity of CYP21A2 gene mutations, there are severe or "classical" forms and moderate or "nonclassical" forms of 21-hydroxylase deficiency. The enzyme deficiency causes a disruption of adrenal steroidogenesis, which induces hyperandrogenism and elevated plasma levels of progesterone and 17-hydroxyprogesterone, the two substrates of 21-hydroxylase. These endocrine abnormalities will disrupt gonadal axis, endometrial growth and maturation and finally secretion of cervical mucus. All these phenomena contribute to a female hypofertility. Infertility is more severe in classical forms. When to become pregnant, treatment with hydrocortisone or dexamethasone can limit the production of adrenal androgens and progesterone and improves spontaneous pregnancy rates while minimizing the risk of miscarriage, which is usually relatively high in this disease. When planning pregnancy in patients with a 21-hydroxylase deficiency, genotyping the partner is required to screen for heterozygozity (1/50) and to assess the risk of transmission of a classical form in the progeny.
Keywords: Congenital adrenal hyperplasia; Déficit en 21-hydroxylase; Gene CYP21A2; Glucocorticoïdes; Gène CYP21A2; Hyperandrogenism; Hyperandrogénie; Hyperplasie congénitale des surrénales; Infertility; Infertilité; Steroid 21-hydroxylase deficiency.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
Similar articles
-
[Health status of adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].Presse Med. 2014 Apr;43(4 Pt 1):428-37. doi: 10.1016/j.lpm.2013.10.006. Epub 2014 Mar 11. Presse Med. 2014. PMID: 24630263 Clinical Trial. French.
-
Molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an update of new CYP21A2 mutations.Clin Chem Lab Med. 2010 Aug;48(8):1057-62. doi: 10.1515/CCLM.2010.239. Clin Chem Lab Med. 2010. PMID: 20482300 Review.
-
Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.J Clin Endocrinol Metab. 2010 Mar;95(3):1182-90. doi: 10.1210/jc.2009-1383. Epub 2010 Jan 15. J Clin Endocrinol Metab. 2010. PMID: 20080854
-
Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Exp Clin Endocrinol Diabetes. 2006 Apr;114(4):208-14. doi: 10.1055/s-2006-924072. Exp Clin Endocrinol Diabetes. 2006. PMID: 16705555
-
Genetics of adrenal steroid 21-hydroxylase deficiency.Endocr Rev. 1986 Aug;7(3):331-49. doi: 10.1210/edrv-7-3-331. Endocr Rev. 1986. PMID: 3527688 Review.
Cited by
-
A rare case report about a congenital adrenal hyperplasia by 21-hydroxylase lock in its pure virilizing form discovered in adolescence.Ann Med Surg (Lond). 2022 Apr 28;78:103673. doi: 10.1016/j.amsu.2022.103673. eCollection 2022 Jun. Ann Med Surg (Lond). 2022. PMID: 35592826 Free PMC article.
-
Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Endocrine. 2020 Aug;69(2):262-277. doi: 10.1007/s12020-020-02323-3. Epub 2020 May 5. Endocrine. 2020. PMID: 32367336 Free PMC article. Review.
-
Health problems of adolescent and adult patients with 21-hydroxylase deficiency.Clin Pediatr Endocrinol. 2018;27(4):203-213. doi: 10.1297/cpe.27.203. Epub 2018 Oct 30. Clin Pediatr Endocrinol. 2018. PMID: 30393437 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials